Results 21 to 30 of about 14,898,836 (369)

Haemophilia specialist nurses’ perceptions of haemophilia B

open access: yesThe Journal of Haemophilia Practice, 2021
Some clinicians believe that haemophilia B is associated with less bleeding than haemophilia A, yet there appears to be little difference in health-related outcomes.
Chaplin Steve   +9 more
doaj   +1 more source

The use of rIX-FP in patients with haemophilia B: a nurse's perspective

open access: yesThe Journal of Haemophilia Practice, 2021
The management of patients with haemophilia is complex and requires lifelong care to be delivered by a specialist multidisciplinary team. Haemophilia B results from a deficiency or absence in coagulation factor IX (FIX), leading to easy bruising, and ...
Garner Kara   +2 more
doaj   +1 more source

Realistic Calculation of the hep Astrophysical Factor [PDF]

open access: yes, 2000
The astrophysical factor for the proton weak capture on 3He is calculated with correlated-hyperspherical-harmonics bound and continuum wave functions corresponding to a realistic Hamiltonian consisting of the Argonne v18 two-nucleon and Urbana-IX three ...
A. E. Cox   +36 more
core   +3 more sources

Center-of-mass corrections revisited: a many-body expansion approach [PDF]

open access: yes, 1998
A many-body expansion for the computation of the charge form factor in the center-of-mass system is proposed. For convergence testing purposes, we apply our formalism to the case of the harmonic oscillator shell model, where an exact solution exists.
Heisenberg, Jochen H., Mihaila, Bogdan
core   +2 more sources

Triton Electric Form Factor at Low-Energies [PDF]

open access: yes, 2009
Making use of the Effective Field Theory(EFT) expansion recently developed by the authors, we compute the charge form factor of triton up to next-to-next-to-leading order (N$^2$LO).
Hossein Sadeghi, Jafar Nezamdost
core   +1 more source

APTAMERS ARE NEW PHARMACOLOGICAL SUBSTANCES FOR THE DEVELOPMENT OF ANTICOAGULANTS

open access: yesАтеротромбоз, 2017
A ptamers are a new class of oligonucleotide compounds capable of specific binding to various molecular targets and inhibiting their activity. Aptamers are selected from a library of randomly syn-thesized oligonucleotides (from 20 to 60 nucleotides long)
A. V. Mazurov, V. A. Spiridonova
doaj   +1 more source

Ion Exchange-Precipitation for Nutrient Recovery from Dilute Wastewater [PDF]

open access: yes, 2015
Regulated phosphorus (P) and nitrogen (N) discharges and the cost of fertilizer provide economic drivers for nutrient removal and recovery from wastewater.
Mayer, Brooke K.   +2 more
core   +2 more sources

Real-World Amount of Clotting Factor Concentrates Dispensed and Annual Medical Expenditures for Japanese Patients with Hemophilia B

open access: yesJournal of Blood Medicine, 2023
Katsuyuki Fukutake,1,2 Kanae Togo,3 Linghua Xu,3 Leona E Markson,4 José Maria Jimenez Alvir,5 Ian Winburn,6 Toshiyuki Karumori3 1Laboratory Medicine, Tokyo Medical University, Shinjuku, Tokyo, Japan; 2Department of Blood Coagulation Diseases, Ogikubo ...
Fukutake K   +6 more
doaj  

Hyperactivity of factor IX Padua (R338L) depends on factor VIIIa cofactor activity.

open access: yesJCI Insight, 2019
Adeno-associated-viral (AAV) vector liver-directed gene therapy (GT) for hemophilia B (HB) is limited by a vector-dose-dependent hepatotoxicity. Recently, this obstacle has been partially circumvented by the use of a hyperactive factor IX (FIX) variant ...
Benjamin J. Samelson-Jones   +4 more
semanticscholar   +1 more source

Factor IX p.A37V mutation causes severe bleeding in a patient with phenprocoumon therapy

open access: yesEuropean Journal of Medical Research, 2021
Background Bleeding is the most common complication of oral anticoagulants, due to inadequate dosing. Case presentation This report describes the clinical course of a patient who developed severe bleeding under therapy with phenprocoumon, despite an INR ...
Nils Mülling   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy